Baldino, Carmen M.,Caserta, Justin L.,Lee, Chee-seng,Dumas, Stephane A.,Flanders, Yvonne L.
申请号：
AU2012332931
公开号：
AU2012332931B2
申请日:
2012.10.24
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Disclosed are aminopyrimidine compounds, pharmaceutical compositions containing those compounds, and uses of the compounds and compositions as modulators of CK 1, CKIyl, CKIy2, CKIy3, CK2, Pim 1, Pim2, Pim3, the TGFβ pathway, the Wnt pathway, the JAK/STAT pathway, the AKT pathway, and/or the mTOR pathway. Uses arc also disclosed for the treatment or prevention of a range of therapeutic indications due at least in part to aberrant physiological activity of CK1, CKIyl, CKIy2, CKIy3, CK2, Pim 1, Pim2, Pim3, the TGFβ pathway, the Wnt pathway, the JAK/STAT pathway, the AKT pathway, and/or the mTOR pathway.
